NCT05834829
Low-intensity Focused Ultrasound and Autonomic Response
Enrolling by Invitation
NAAges 18–65InterventionalBasic scienceVirginia Polytechnic Institute and State UniversityInvestigator-initiated
~80 participants
Updated 2026-06-08 on ClinicalTrials.gov
What's tested:Low-intensity focused ultrasound neuromodulationSham Low-intensity focused ultrasound
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Sympathetic tone response - Heart Rate Variability (HRV)
Measured over through study completion, an average of 1 month
+4 more outcomes measured
Conditions
NCT05834829
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Fralin Biomedical Research Institute at VTC
Roanoke, Virginiano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Exclusion
Claustrophobia (scanning environment may be uncomfortable).
Contraindications to MRI: including pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, steel worker, or other implants.
Contraindications to CT: pregnancy
Active medical disorder or treatment with potential central nervous system (CNS) effects (e.g. Alzheimer's) -
History of neurologic disorder. (e.g. Parkinson's, Epilepsy, or Essential Tremor)
History of head injury resulting in loss of consciousness for \>10 minutes.
History of alcohol or drug dependence (through self-report).
History of cardiac disease
A current or prior use of any cardiac medication (e.g. beta blockers or other anti-arrhythmics)
A history of diabetes mellitus or use of diabetic medications (e.g. metformin).
What this trial measures
- Sympathetic tone response - Heart Rate Variability (HRV)through study completion, an average of 1 month
Changes in HRV
- Sympathetic tone response - Heart Rate (HR)through study completion, an average of 1 month
Changes in HR
- Sympathetic tone response - Blood Pressure (BP)through study completion, an average of 1 month
Changes in BP (systolic and diastolic pressure)
- Sympathetic tone response - Electrodermal Response (EDR)through study completion, an average of 1 month
Changes in EDR
- Sympathetic tone response - Electroencephalography (EEG)through study completion, an average of 1 month
Changes in low and high frequency power